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Background:  Left atrial volume index (LAVI) as a marker for discrimination of risk for stroke and transient ischemic attack (TIA) in patients with 
atrial fibrillation (AF) and low risk CHADS2 scores (≤1) has yet to be conclusively determined.
Methods:  Patients with AF, stroke or TIA, and CHADS2 scores ≤1 prior to their event were identified from a large single center stroke registry 
and compared to age and gender matched controls. Antihypertensive use and echocardiographic parameters including chamber volumes and left 
ventricular (LV) mass were compared between groups. Fifty seven cases meeting entry criteria were identified.
Results:  Cases demonstrated significantly lower left ventricular ejection fraction (LVEF), higher left atrial (LA) dimension, and larger LAVI (25.3 
+11.0 ml/m2 vs 31.5 + 13.1ml/m2, p=0.005) compared to controls. Controls were more likely to demonstrate a normal LVEF (≥55%) and normal 
LAVI (≤28ml./m2) compared to cases (p=0.005). Conversely, cases demonstrated reduced systolic function and increased LAVI more frequently than 
controls (p=0.002). The ROC curve for LAVI as a positive predictor for stroke or TIA was significant (AUC=0.67, p=0.002).
Conclusions:  In low risk patients with AF and stroke or TIA, LAVI is significantly elevated, and LVEF is significantly reduced compared to age 
and gender matched controls. These results suggest that LAVI may have potential as a tool for helping to guide the decision for or against oral 
anticoagulation in this group of patients.
